Zydus 2-dose Covid-19 vaccine gets regulatory nod | India News – Times of India

Zydus 2-dose Covid-19 vaccine gets regulatory nod | India News – Times of India

Zydus Lifesciences announced its Covid-19 vaccine, ZyCoV-D has received emergency use authorisation (EUA) from the country’s drug regulator as a two-dose vaccine.
With this approval, the vaccine will now be administered on day 0 and day 28. Earlier, the vaccine was approved in a three-dose regimen to be administered on day 0, day 28 and day 56.
Speaking on the development, Sharvil Patel managing director Zydus Lifesciences said, “This will increase the compliance for the vaccine and reduce the overall time required for vaccination to improve immunity against the virus. It will also help in administering the vaccine in a larger population in a shorter time which is always desirable in the midst of a pandemic.”
The two dose regimen for ZyCoV-D was tested in 3100 healthy volunteers more than 12 years of age.
Earlier this month TOI reported that the company received approval from the Subject Expert Committee (SEC) under the health ministry, paving the way for a nod by the drug regulator.

!function(f,b,e,v,n,t,s) {if(f.fbq)return;n=f.fbq=function(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}; if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version=’2.0′; n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0]; s.parentNode.insertBefore(t,s)}(window, document,’script’, ‘https://connect.facebook.net/en_US/fbevents.js’); fbq(‘init’, ‘593671331875494’); fbq(‘track’, ‘PageView’);

Source link